Jacob D Soumerai and Andrew D Zelenetz on the...

Dr Erica Kaye and Dr Dylan Graetz join us to discuss the importance of qualitative research and how the whole research ecosystem can incorporate and support this type of research to help set the right research questions, and promote the patient voice.Click here to read the full a ...  Show more

Professor Isabelle Mahé joins us to discuss the results of a post-hoc analysis of the API-CAT trial identifying predictors associated with clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism.Click here to read the full article ...  Show more

Join experts Drs Matt Sparks and Dawn Caster as they discuss the complexities around the management of lupus nephritis. What tools do we have now? What is on the horizon? Tune in to find out. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.m ...  Show more

Join Drs Matthew Sparks and Kirk Campbell as they dive into the murky waters of focal segmental glomerular sclerosis. How do you diagnose? How do you treat? Tune in to find out. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.medscape.com/vi ...  Show more

<span class= "WdYUQQ text-decoration-none text-strikethrough-none">Dr. Kathryn Nevel talks with Dr. Ingo Mellinghoff about how vorasidenib improved progression-free survival in patients with Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas.</span>

<span class= "WdY ...

Dr. Vikram Karnik and Dr. Rob de Bie discuss early vs. delayed start of Levodopa in early Parkinson disease, and what it means for our clinical practice. Show reference: https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mds.29796   This podcast is sponsored by arg ...  Show more